A5038634216- Health Systems, Economic Evaluations, Quality of Life
- Renal cell carcinoma treatment
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Nutrition and Health in Aging
- Gastric Cancer Management and Outcomes
- Pharmaceutical Economics and Policy
- Cancer Genomics and Diagnostics
- Frailty in Older Adults
- Blood Pressure and Hypertension Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Global Public Health Policies and Epidemiology
- Renal Diseases and Glomerulopathies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Neuroscience and Neural Engineering
- Complement system in diseases
- Hepatitis C virus research
- Bariatric Surgery and Outcomes
- Pharmaceutical studies and practices
- Obesity, Physical Activity, Diet
- Liver Disease Diagnosis and Treatment
- Diet and metabolism studies
- Global Health Care Issues
- Uterine Myomas and Treatments
UPMC Center for High Value Health Care
2023
German Agency for Quality in Medicine
2013-2022
Maastricht University
2016-2022
MIMOT (Germany)
2013-2019
Association on Higher Education And Disability
2017
Abstract Background Despite growth of robotic surgery, published literature lacks assessment the cost ownership (CoO) a da Vinci robot by surgical service line and associated benefit such data provides. Methods Based on real‐world (RWD) from 14 US hospitals ≈6000 cases, CoO was assessed using all relevant fixed variable components, calculated line. Results At representative hospital with an efficient program (n = 424 cases), weighted average per case $984. Weighted $8025 (range: $3325 for...
Hepatitis C virus (HCV) is a global public health crisis. Egypt presents the highest HCV prevalence. Recently, three different screening/testing/therapy programs were implemented: In 2014 (wave 1), major decisions on therapy enacted, accompanied by 99% discount for sofosbuvir. 2016 2), first testing program was launched to identify patients free treatment. 2018 3), population-wide screening conducted using WHO-prequalified finger prick rapid diagnostic test (RDT) identify/treat all Egyptians...
⎥
Lung cancer is the leading cause of deaths worldwide (1.38 million deaths, 18.2% total) and morbidity (1.61 new cases, 12.7% all cancers). Currently only three second-line non-small-cell lung (NSCLC) pharmacotherapies are licensed in European Union: chemotherapies pemetrexed docetaxel epidermal growth factor receptor tyrosine kinase inhibitor erlotinib. These therapy alternatives have shown a comparable efficacy (survival benefit). In past, cost comparisons showed that erlotinib was less...
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the potential to improve blind patients with retinitis pigmentosa (RP) a manner that they will be categorized as visual impaired but no more blind. This unprecedented improvement result mentionable quality life gain poses question at costs AVDs are regarded cost-effective, from German healthcare payer perspective. In order answer this research Markov model was simulate and...
This research aims to (1) replicate published health economic models, (2) compare reproduced results with original results, (3) identify facilitators and hurdles model replicability determine reproduction success, (4) suggest replication reporting standards enhance reproducibility, in the context of obesity models. Four models simulating an adult UK population were identified, selected for replication, evaluated using Consolidated Health Economic Evaluation Reporting Standards (CHEERS)...
4612 Background: There are currently three licensed first-line metastatic renal cell carcinoma (mRCC) targeted therapies, allowing the therapy of a broad mRCC population with good or intermediate prognosis: vascular endothelial growth factor inhibitor bevacizumab (BEV) given in combination interferon-alpha-2a (IFN), and tyrosine kinase inhibitors (TKI) sunitinib (SUN) pazopanib (PAZ). All have shown significant increase progression-free survival (PFS) therapy. These therapies competing to be...
To compare personalized dosimetry with yttrium-90 (
Introduction: Diabetes imposes clinical and economic burdens on healthcare systems worldwide. For people with diabetes, having poor nutritional status increases risks for complications outcomes, thus raising costs healthcare. Our analysis assessed the impact of a nutrition-focused quality improvement program (QIP) outcomes older community-living adults diabetes. Research design methods: Eligible patients were ≥ 60 years receiving care at an outpatient clinic in Bogotá, Colombia. Enrollees...